T1	Participants 159 178	bipolar 1 disorder.
T2	Participants 210 253	patients with manic and mixed mood episodes
T3	Participants 486 602	patients presenting with a mixed index episode who were enrolled in a larger double-blind, placebo-controlled trial.
T4	Participants 603 725	Patients who met remission criteria at 2 consecutive weekly visits during 6 to 12 weeks of open-label olanzapine treatment
T5	Participants 968 987	121 of 304 patients
T6	Participants 1677 1746	patients presenting with a mixed index episode of bipolar I disorder.
